Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 6, 2024Signal Transduction and Targeted TherapyOpen Access

First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHuizi ShaFTFan TongJNJiayao Ni

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sha et al. (2024) studied this question.

synapsesocial.com/papers/68e65d00b6db6435875eafechttps://doi.org/10.1038/s41392-024-01857-6
View Full Paper
Ask AI
Bookmark
Share